These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 22237841)

  • 21. I-131 MIBG scintigraphy of neuroectodermal tumors. Comparison between I-131 MIBG and In-111 DTPA-octreotide.
    Lauriero F; Rubini G; D'Addabbo F; Rubini D; Schettini F; D'Addabbo A
    Clin Nucl Med; 1995 Mar; 20(3):243-9. PubMed ID: 7750219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simultaneous 68Ga-DOTATOC PET/MRI in patients with gastroenteropancreatic neuroendocrine tumors: initial results.
    Beiderwellen KJ; Poeppel TD; Hartung-Knemeyer V; Buchbender C; Kuehl H; Bockisch A; Lauenstein TC
    Invest Radiol; 2013 May; 48(5):273-9. PubMed ID: 23493121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utility of thallium-201 and iodine-123 metaiodobenzylguanidine in the scintigraphic detection of neuroendocrine neoplasia.
    Montravers F; Coutris G; Sarda L; Mensch B; Talbot JN
    Eur J Nucl Med; 1993 Nov; 20(11):1070-7. PubMed ID: 8287875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 123I-MIBG scintigraphy and 18F-FDG PET in neuroblastoma.
    Nguyen NC; Bhatla D; Osman MM
    J Nucl Med; 2010 Feb; 51(2):330-1; author reply 331. PubMed ID: 20080890
    [No Abstract]   [Full Text] [Related]  

  • 25. Current concepts on the diagnostic use of MIBG in children.
    Shulkin BL; Shapiro B
    J Nucl Med; 1998 Apr; 39(4):679-88. PubMed ID: 9544682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alteration of myocardial metaiodobenzylguanidine uptake after treatment of phaeochromocytoma and neuroblastoma.
    Suga K; Ogasawara N; Ariga M; Motoyama K; Hara A; Kume N; Matsunaga N
    Eur J Nucl Med; 2000 May; 27(5):574-82. PubMed ID: 10853814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 99mTc-HYNIC-TOC scintigraphy is superior to 131I-MIBG imaging in the evaluation of extraadrenal pheochromocytoma.
    Chen L; Li F; Zhuang H; Jing H; Du Y; Zeng Z
    J Nucl Med; 2009 Mar; 50(3):397-400. PubMed ID: 19223405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of [68Ga]DOTANOC PET/computed tomography and [131I]MIBG scintigraphy in the management of patients with pheochromocytoma and paraganglioma: a prospective study.
    Singh D; Shukla J; Walia R; Vatsa R; Paul N; Chhabra A; Nahar U; Singh H; Kumar R; Bhansali A; Rai Mittal B
    Nucl Med Commun; 2020 Oct; 41(10):1047-1059. PubMed ID: 32732602
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Kroiss AS; Uprimny C; Shulkin BL; Gruber L; Frech A; Url C; Riechelmann H; Sprinzl GM; Thomé C; Treglia G; Kjaer A; Fraedrich G; Virgolini IJ
    Nucl Med Biol; 2019 Apr; 71():47-53. PubMed ID: 31152973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac pheochromocytomas detected by Tc-99m-hydrazinonicotinyl-Tyr3-octreotide (HYNIC-TOC) scintigraphy.
    Chen L; Li F; Zhuang H; Jing H; Du Y; Zeng Z
    Clin Nucl Med; 2007 Mar; 32(3):182-5. PubMed ID: 17314591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [68Ga-DOTA-PET for neuroendocrine tumours].
    Loimaala A; Mäenpää H; Lipponen T; Schildt J; Kämäräinen EL; Karhumäki L; Ahonen A
    Duodecim; 2014; 130(19):1931-8. PubMed ID: 25558614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography for the assessment of 131I-metaiodobenzylguanidine therapy in malignant phaeochromocytoma.
    Nakazawa A; Higuchi T; Oriuchi N; Arisaka Y; Endo K
    Eur J Nucl Med Mol Imaging; 2011 Oct; 38(10):1869-75. PubMed ID: 21732103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imaging neural crest tumours with 123I-metaiodobenzylguanidine and X-ray computed tomography: a comparative study.
    Bomanji J; Conry BG; Britton KE; Reznek RH
    Clin Radiol; 1988 Sep; 39(5):502-6. PubMed ID: 2846227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 18F-FDG PET/CT and 123I-metaiodobenzylguanidine imaging in high-risk neuroblastoma: diagnostic comparison and survival analysis.
    Papathanasiou ND; Gaze MN; Sullivan K; Aldridge M; Waddington W; Almuhaideb A; Bomanji JB
    J Nucl Med; 2011 Apr; 52(4):519-25. PubMed ID: 21421719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Scintigraphic diagnosis of neuroblastoma and pheochromocytoma with 131I-meta-iodobenzylguanidine in pediatrics].
    Mussa GC; Silvestro L
    Minerva Pediatr; 1984 Oct; 36(19):919-22. PubMed ID: 6530994
    [No Abstract]   [Full Text] [Related]  

  • 36. 123I-MIBG versus 18F-FDG: which is better, or which can be eliminated?
    Heston TF
    J Nucl Med; 2010 Feb; 51(2):330; author reply 331. PubMed ID: 20080883
    [No Abstract]   [Full Text] [Related]  

  • 37. Nuclear medicine imaging of pheochromocytoma and neuroblastoma.
    Sisson JC; Shulkin BL
    Q J Nucl Med; 1999 Sep; 43(3):217-23. PubMed ID: 10568137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [131I-meta-iodobenzylguanidine (MIBG) for the detection and therapy of pheochromocytoma and neuroblastoma].
    Nakajo M; Shinohara S
    Rinsho Hoshasen; 1987 Apr; 32(4):461-70. PubMed ID: 3613180
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of [123I]MIBG and [131I]MIBG for imaging of neuroblastoma and other neural crest tumors.
    Liu B; Zhuang H; Servaes S
    Q J Nucl Med Mol Imaging; 2013 Mar; 57(1):21-8. PubMed ID: 23474632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unusual Bone Superscan, MIBG Superscan, and 68Ga DOTATATE PET/CT in Metastatic Pheochromocytoma.
    Tan TH; Wong TH; Hassan SZ; Lee BN
    Clin Nucl Med; 2015 Nov; 40(11):867-8. PubMed ID: 26252329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.